The trademark application ACEPODIA was filed by Acepodia Biotechnologies Ltd, a corporation established under the laws of Taiwan, Republic of China (the "Applicant"). Application withdrawn.
The application was filed in English (German was selected as the second language).
Goods And Services
The mark was filed in class 42 with following description of goods:
Design and testing for new cell product development, namely, natural killer cell, gamma delta T cell, stem cell, or other cell product development
Platform as a service (PAAS) to develop cell products to improve ability to target tumor cells or other abnormal cells
Platform as a service (PAAS) for use with cell therapy to manufacture tumor targeted or abnormal cell targeted cell products for use in the prevention and treatment of cancer, tumors, hematologic disease, solid cancers, hyperproliferative disease
Providing information of cells and cell-derived preparations
Design and testing for new cell product development for use in the fields of cell therapy and regenerative medicine services.